JAC Advance Access originally published online on March 24, 2005
Journal of Antimicrobial Chemotherapy 2005 55(5):780-784; doi:10.1093/jac/dki087
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Anti-proliferative synergy of lysophospholipid analogues and ketoconazole against Trypanosoma cruzi (Kinetoplastida: Trypanosomatidae): cellular and ultrastructural analysis
1 Departmento de Ultra-estrutura e Biologia Celular, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, CP 926, 21045-900, Rio de Janeiro, Brazil; 2 Laboratorio de Química Biológica, Centro de Biofísica y Bioquímica, Instituto Venezolano de Investigaciones Científicas, Apartado Postal 21.627, Caracas 1020A, Venezuela
* Corresponding author. Tel: +55-21-25984330; Fax: +55-21-2604434; Email: solange{at}ioc.fiocruz.br
Objectives: Investigation of the antiproliferative synergy of the lysophospholipid analogues (LPAs) edelfosine, ilmofosine and miltefosine with the ergosterol biosynthesis inhibitor ketoconazole against Trypanosoma cruzi.
Methods: The effect of LPAs, ketoconazole and their combination was evaluated against epimastigotes and intracellular amastigotes by the parameter IC50 leading to construction of isobolograms, for determination of a synergic effect. For epimastigotes, ultrastructural damage induced by these treatments was evaluated by transmission and scanning electron microscopy.
Results: Synergy was confirmed against both epimastigotes and amastigotes of the parasite. Edelfosine or ketoconazole alone induced morphological alterations in the plasma membrane and reservosomes of the parasites, while in combination, they also led to severe mitochondrial damage, formation of autophagic structures and multinucleation. Scanning electron microscopy confirmed the effect at the plasma membrane and also revealed alterations in the shape of the parasites.
Conclusions: Our results describe the synergic anti-proliferative effect of LPAs and ketoconazole against epimastigotes and intracellular amastigotes and suggest that in epimastigotes, plasma membrane, reservosomes and mitochondria are targets of these drugs, possibly by interference with lipid metabolism.
Keywords: T. cruzi , chemotherapy , edelfosine , ilmofosine , miltefosine , synergy
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
K. Salomao, E. M. de Souza, A. Henriques-Pons, H. S. Barbosa, and S. L. de Castro Brazilian Green Propolis: Effects In Vitro and In Vivo on Trypanosoma cruzi Evid. Based Complement. Altern. Med., March 11, 2009; (2009) nep014v2. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. E. Alvarez, G. Kosec, C. Sant'Anna, V. Turk, J. J. Cazzulo, and B. Turk Autophagy Is Involved in Nutritional Stress Response and Differentiation in Trypanosoma cruzi J. Biol. Chem., February 8, 2008; 283(6): 3454 - 3464. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. L. Uzcategui, D. Carmona-Gutierrez, V. Denninger, C. Schoenfeld, F. Lang, K. Figarella, and M. Duszenko Antiproliferative Effect of Dihydroxyacetone on Trypanosoma brucei Bloodstream Forms: Cell Cycle Progression, Subcellular Alterations, and Cell Death Antimicrob. Agents Chemother., November 1, 2007; 51(11): 3960 - 3968. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Luque-Ortega and L. Rivas Miltefosine (Hexadecylphosphocholine) Inhibits Cytochrome c Oxidase in Leishmania donovani Promastigotes Antimicrob. Agents Chemother., April 1, 2007; 51(4): 1327 - 1332. [Abstract] [Full Text] [PDF] |
||||


